av/celyad-oncology-sa--big.svg

    COM:CELYAD

    Celyad Oncology

    • Stock

    0.53

    −3.28%

    −0.02

    EUR last updated 01/04 01:29:30

    Last Close

    0.55

    31/03 15:35

    Market Cap

    11.14M

    Beta: -

    Volume Today

    13.66K

    Avg: -

    • name

      Celyad Oncology SA
    • homepage url

      www.celyad.com
    • country

      BEBelgium
    • employee count

      17
    • sector

      Healthcare
    • industry

      Biotechnology
    • revenue

      110.35K

    Description

    Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA ...Show More

    peer of